281 related articles for article (PubMed ID: 35157266)
1. Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications.
Ji F; Ren J; Vincke C; Jia L; Muyldermans S
Methods Mol Biol; 2022; 2446():3-17. PubMed ID: 35157266
[TBL] [Abstract][Full Text] [Related]
2. Nanobodies: natural single-domain antibodies.
Muyldermans S
Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
[TBL] [Abstract][Full Text] [Related]
3. Introduction to heavy chain antibodies and derived Nanobodies.
Vincke C; Muyldermans S
Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
[TBL] [Abstract][Full Text] [Related]
4. Applications of nanobodies in plant science and biotechnology.
Wang W; Yuan J; Jiang C
Plant Mol Biol; 2021 Jan; 105(1-2):43-53. PubMed ID: 33037986
[TBL] [Abstract][Full Text] [Related]
5. CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells.
Schütze K; Petry K; Hambach J; Schuster N; Fumey W; Schriewer L; Röckendorf J; Menzel S; Albrecht B; Haag F; Stortelers C; Bannas P; Koch-Nolte F
Front Immunol; 2018; 9():2553. PubMed ID: 30524421
[TBL] [Abstract][Full Text] [Related]
6. Variable fragments of heavy chain antibodies (VHHs): a new magic bullet molecule of medicine?
Smolarek D; Bertrand O; Czerwinski M
Postepy Hig Med Dosw (Online); 2012 Jun; 66():348-58. PubMed ID: 22706121
[TBL] [Abstract][Full Text] [Related]
7. Isolation and Characterization of Single-Domain Antibodies from Immune Phage Display Libraries.
Rossotti MA; Trempe F; van Faassen H; Hussack G; Arbabi-Ghahroudi M
Methods Mol Biol; 2023; 2702():107-147. PubMed ID: 37679618
[TBL] [Abstract][Full Text] [Related]
8. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
Liu B; Yang D
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
[TBL] [Abstract][Full Text] [Related]
9. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.
Wesolowski J; Alzogaray V; Reyelt J; Unger M; Juarez K; Urrutia M; Cauerhff A; Danquah W; Rissiek B; Scheuplein F; Schwarz N; Adriouch S; Boyer O; Seman M; Licea A; Serreze DV; Goldbaum FA; Haag F; Koch-Nolte F
Med Microbiol Immunol; 2009 Aug; 198(3):157-74. PubMed ID: 19529959
[TBL] [Abstract][Full Text] [Related]
10. A megadiverse naïve library derived from numerous camelids for efficient and rapid development of VHH antibodies.
Wang M; Wei L; Xiang H; Ren B; Liu X; Jiang L; Yang N; Shi J
Anal Biochem; 2022 Nov; 657():114871. PubMed ID: 36108795
[TBL] [Abstract][Full Text] [Related]
11. Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies.
Zavrtanik U; Lukan J; Loris R; Lah J; Hadži S
J Mol Biol; 2018 Oct; 430(21):4369-4386. PubMed ID: 30205092
[TBL] [Abstract][Full Text] [Related]
12. Characterization of heavy-chain antibody gene repertoires in Bactrian camels.
Liu Y; Yi L; Li Y; Wang Z; Jirimutu
J Genet Genomics; 2023 Jan; 50(1):38-45. PubMed ID: 35500746
[TBL] [Abstract][Full Text] [Related]
13. Generation, expression and utilization of single-domain antibodies for in vivo protein localization and manipulation in sea urchin embryos.
Schrankel CS; Gökirmak T; Lee CW; Chang G; Hamdoun A
Methods Cell Biol; 2019; 151():353-376. PubMed ID: 30948018
[TBL] [Abstract][Full Text] [Related]
14. The development of nanobodies for therapeutic applications.
Van Bockstaele F; Holz JB; Revets H
Curr Opin Investig Drugs; 2009 Nov; 10(11):1212-24. PubMed ID: 19876789
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical improvement of rabbit derived single-domain antibodies by substitutions with amino acids conserved in camelid antibodies.
Shinozaki N; Hashimoto R; Noda M; Uchiyama S
J Biosci Bioeng; 2018 Jun; 125(6):654-661. PubMed ID: 29398547
[TBL] [Abstract][Full Text] [Related]
16. Generation of single domain antibody fragments derived from camelids and generation of manifold constructs.
Vincke C; Gutiérrez C; Wernery U; Devoogdt N; Hassanzadeh-Ghassabeh G; Muyldermans S
Methods Mol Biol; 2012; 907():145-76. PubMed ID: 22907350
[TBL] [Abstract][Full Text] [Related]
17. Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies.
Clarke SC; Ma B; Trinklein ND; Schellenberger U; Osborn MJ; Ouisse LH; Boudreau A; Davison LM; Harris KE; Ugamraj HS; Balasubramani A; Dang KH; Jorgensen B; Ogana HAN; Pham DT; Pratap PP; Sankaran P; Anegon I; van Schooten WC; Brüggemann M; Buelow R; Force Aldred S
Front Immunol; 2018; 9():3037. PubMed ID: 30666250
[TBL] [Abstract][Full Text] [Related]
18. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
[TBL] [Abstract][Full Text] [Related]
19. Development of Antibody and Nanobody Tools for P2X7.
Stähler T; Danquah W; Demeules M; Gondé H; Hardet R; Haag F; Adriouch S; Koch-Nolte F; Menzel S
Methods Mol Biol; 2022; 2510():99-127. PubMed ID: 35776322
[TBL] [Abstract][Full Text] [Related]
20. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs).
Maass DR; Sepulveda J; Pernthaner A; Shoemaker CB
J Immunol Methods; 2007 Jul; 324(1-2):13-25. PubMed ID: 17568607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
